1. Home
  2. BGLC vs BNGO Comparison

BGLC vs BNGO Comparison

Compare BGLC & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioNexus Gene Lab Corp

BGLC

BioNexus Gene Lab Corp

HOLD

Current Price

$2.20

Market Cap

10.1M

Sector

Health Care

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.19

Market Cap

11.6M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGLC
BNGO
Founded
2017
2003
Country
Malaysia
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Laboratory Analytical Instruments
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
11.6M
IPO Year
2019
2018

Fundamental Metrics

Financial Performance
Metric
BGLC
BNGO
Price
$2.20
$1.19
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$7.50
AVG Volume (30 Days)
5.5K
267.9K
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
45.78
94.50
EPS
N/A
N/A
Revenue
$9,510,646.00
$12,000,735.00
Revenue This Year
N/A
$16.19
Revenue Next Year
N/A
$33.34
P/E Ratio
N/A
N/A
Revenue Growth
N/A
26.26
52 Week Low
$1.92
$1.06
52 Week High
$15.19
$5.50

Technical Indicators

Market Signals
Indicator
BGLC
BNGO
Relative Strength Index (RSI) 41.29 52.09
Support Level $2.12 $1.07
Resistance Level $2.73 $1.64
Average True Range (ATR) 0.11 0.08
MACD -0.02 0.01
Stochastic Oscillator 12.55 29.73

Price Performance

Historical Comparison
BGLC
BNGO

About BGLC BioNexus Gene Lab Corp

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.

Share on Social Networks: